by 作者 Arsenio Toledo 阿塞尼奥·托莱多
Around 97 percent of Wuhan coronavirus(COVID-19)cases in the Delhi metropolitan area in India have been effectively dealt with thanks to the widespread use of ivermectin.
由于伊维菌素的广泛使用，在印度德里的2019冠状病毒疾病城市群中，大约97%的武汉冠状病毒病例得到了有效处理。
Earlier in the year,India dealt with a devastating post-vaccine wave of the coronavirus.This post-vaccine outbreak affected the country differently.In states that did not use ivermectin,cases soared.But the data shows that by the end of May,this second wave of COVID-19 was under control in parts of the country that treated patients with ivermectin.(Related:Indian state with 240 million people completely eradicated covid with ivermectin.)
今年早些时候，印度应对了疫苗后冠状病毒的毁灭性浪潮。这次疫苗后的爆发对这个国家产生了不同的影响。在没有使用伊维菌素的州，病例飙升。但是数据显示，到5月底，这第二波2019冠状病毒疾病已经在伊维菌素治疗的国家部分地区得到控制。(相关报道:印度有2.4亿人使用伊维菌素彻底根除了Ｃovid。)
In Delhi,health authorities began treating patients with ivermectin on April 20.At the time,the metropolitan area of 30 million people was dealing with nearly 30,000 new cases daily.
在德里，卫生当局从4月20日开始用伊维菌素治疗病人。当时，拥有3000万人口的城市群每天要处理近30000个新病例。
By the end of May,COVID-19 cases in the metro area were down to less than 1,000 new cases per day.This is a 97 percent reduction in new COVID-19 cases in just five weeks.
到5月底，大都市地区的2019冠状病毒疾病病例已经下降到每天不到1000例。这是在短短5周内，2019冠状病毒疾病新增病例减少了97%。
The number of deaths per day also fell from nearly 300 in April to slightly above 100 by the end of May.
每天的死亡人数也从4月的近300人下降到5月底的略高于100人。
Similarly,momentous drops in COVID-19 cases could also be seen in at least four other Indian states that used ivermectin for its COVID-19 patients.
同样地，在印度其他至少4个使用伊佛霉素治疗2019冠状病毒疾病2019冠状病毒疾病患者的邦，也可以看到伊佛霉素病例的重大下降。
Of particular note is the northern state of Uttar Pradesh,where health authorities went from dealing with nearly 40,000 new COVID-19 cases per day in late April to just 2,000 new cases per day by the end of May.This is a 95 percent reduction in new cases.
特别值得注意的是北方邦，那里的卫生当局从4月下旬每天处理近40,000个新增2019冠状病毒疾病病例，到5月底每天仅处理2,000个新增病例。新病例减少了95%。
Meanwhile,in states that did not use ivermectin,the number of new COVID-19 cases they were dealing with kept on growing.
与此同时，在那些没有使用伊维菌素的州，他们正在处理的新的2019冠状病毒疾病病例数量持续增长。
The southern state of Tamil Nadu dealt with nearly 11,000 new COVID-19 cases per day by late April.By the end of May,that number had ballooned to over 30,000 new COVID-19 cases daily.
截至4月下旬，南部的 Tamil Nadu 每天处理近11,000个新的2019冠状病毒疾病病例。到五月底，这个数字已经激增到每天超过30,000个新的2019冠状病毒疾病。
Daily deaths due to COVID-19 in Tamil Nadu also rose from 48 on April 20 to 474 on May 27.
在 Tamil Nadu，每天死于2019冠状病毒疾病的人数也从4月20日的48人上升到5月27日的474人。
Ivermectin is still being attacked all over the world
伊维菌素仍然在世界各地受到攻击
In the United States,the Food and Drug Administration still has not approved ivermectin for treating or preventing COVID-19.
在美国，食品和药物管理局仍然没有批准伊维菌素用于治疗或预防2019冠状病毒疾病。
Instead of adopting the use of this cheap and effective drug,advocates of the experimental and deadly vaccines have ridiculed ivermectin as a"horse deworming"medication.Those who ridicule ivermectin like this fail to understand that there are two kinds of ivermectin,one for use for animals such as horses and another for humans.
这种实验性致命疫苗的拥护者并没有采用这种廉价而有效的药物，而是嘲笑伊维菌素是一种"驱虫"药物。那些这样嘲笑伊维菌素的人没有理解伊维菌素有两种，一种用于马等动物，另一种用于人类。
Two of the three winners of the Nobel Prize in Medicine in 2015 won the award for their discovery of ivermectin and its use in treating malaria.This is the version of ivermectin that humans can take and is being used to treat COVID-19.
2015年诺贝尔医学奖的三位获奖者中有两位因发现伊维菌素及其在治疗疟疾中的应用而获奖。这是伊维菌素的一个版本，人类可以服用，目前正用于治疗2019冠状病毒疾病。
Even in India,where the use of ivermectin has saved potentially millions of lives,the medicine is still being attacked by health authorities.The Indian Council of Medical Research(ICMR),the government's main biomedical research body,has discontinued the use of ivermectin and hydroxychloroquine for the management of adult COVID-19 cases.
即使在印度，伊维菌素的使用挽救了数百万人的生命，这种药物仍然受到卫生当局的攻击。印度医学研究委员会，印度政府的主要生物医学研究医学研究机构，已经停止使用伊维菌素和羟氯喹来处理成人2019冠状病毒疾病病例。
Instead of ivermectin and hydroxychloroquine,the ICMR is instead recommending that COVID-19 patients be given remdesivir and tocilizumab,the former of which is known to be more harmful than useful against COVID-19.
与伊维菌素和羟氯喹相反，ICMR 建议2019冠状病毒疾病患者使用雷德西韦和托西利珠单抗，众所周知前者对2019冠状病毒疾病的危害大于有效。
Dr.Justin R.Hope,writing for The Desert Review,argues that if the world had listened to the experts who were advocating for the use of ivermectin,thousands of lives could have been saved both in India and in the United States.
为《沙漠评论》撰稿的贾斯汀·r·霍普博士认为，如果世界听取了那些倡导使用伊维菌素的专家的意见，印度和美国本可以挽救成千上万的生命。
"Delhi did it right.The United States and Tamil Nadu did it wrong,"he wrote."It cost half a million precious lives and horrific pain and suffering for the world.The pandemic was prolonged for no good reason."
"德里做得对。美国和 Tamil Nadu 做错了,"他写道。"它使50万人丧失了宝贵的生命，给世界带来了可怕的痛苦和苦难。流感大流行的延长没有任何正当理由。"
"Now,we are in a different position,"he continues."We as a people have absolute evidence of ivermectin's efficacy.In Delhi,we heard not one single story of ivermectin being toxic or causing any difficulty.On the contrary,it is safe,and it saved tens of thousands from COVID."
"现在，我们处于一个不同的位置,"他继续说道。"作为一个民族，我们拥有伊维菌素疗效的绝对证据。在德里，我们没有听到任何关于伊维菌素有毒或造成任何困难的报道。恰恰相反，它是安全的，而且它从 COVID 中拯救了数万人。"
Learn more about how governments all over the world are trying to prevent COVID-19 patients from being treated with actually useful medications like ivermectin by reading the latest articles at Pandemic.news.
通过阅读 Pandemic.news 的最新文章，了解更多关于世界各国政府如何努力防止2019冠状病毒疾病患者接受实际有用的药物治疗，如伊维菌素。
来源：
https://noqreport.com/2021/09/29/widespread-ivermectin-use-has-caused-a-97-drop-in-coronavirus-cases-in-delhi-india/
